BR0206949A - Derivados de alquil-fenilimino-imidazolidina para tratamento de incontinência urinária - Google Patents

Derivados de alquil-fenilimino-imidazolidina para tratamento de incontinência urinária

Info

Publication number
BR0206949A
BR0206949A BR0206949-0A BR0206949A BR0206949A BR 0206949 A BR0206949 A BR 0206949A BR 0206949 A BR0206949 A BR 0206949A BR 0206949 A BR0206949 A BR 0206949A
Authority
BR
Brazil
Prior art keywords
treatment
urinary incontinence
alkyl
phenylimino
imidazolidine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
BR0206949-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Franz Esser
Pascale Pouzet
Hisato Kitagawa
Kenji Sakai
Ikunobu Muramatsu
Matthias Hoffmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH Co KG filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of BR0206949A publication Critical patent/BR0206949A/pt
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR0206949-0A 2001-02-10 2002-01-22 Derivados de alquil-fenilimino-imidazolidina para tratamento de incontinência urinária Pending BR0206949A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10106214A DE10106214A1 (de) 2001-02-10 2001-02-10 Neue Alkyl-phenylimino-imidazolidin-Derivate zur Behandlung der Harninkontinenz
PCT/EP2002/000576 WO2002064570A1 (de) 2001-02-10 2002-01-22 Neue alkyl-phenylimino-imidazolidin-derivate zur behandlung der harninkontinenz

Publications (1)

Publication Number Publication Date
BR0206949A true BR0206949A (pt) 2004-02-25

Family

ID=7673601

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0206949-0A Pending BR0206949A (pt) 2001-02-10 2002-01-22 Derivados de alquil-fenilimino-imidazolidina para tratamento de incontinência urinária

Country Status (21)

Country Link
EP (1) EP1362038A1 (hu)
JP (1) JP2004517963A (hu)
KR (1) KR20030076653A (hu)
CN (1) CN1491216A (hu)
AR (1) AR035226A1 (hu)
BG (1) BG108036A (hu)
BR (1) BR0206949A (hu)
CA (1) CA2437809A1 (hu)
CZ (1) CZ20032146A3 (hu)
DE (1) DE10106214A1 (hu)
EA (1) EA200300835A1 (hu)
EC (1) ECSP034700A (hu)
EE (1) EE200300379A (hu)
HU (1) HUP0303004A3 (hu)
IL (1) IL157297A0 (hu)
MX (1) MXPA03007127A (hu)
NO (1) NO20033368D0 (hu)
PL (1) PL362149A1 (hu)
SK (1) SK10132003A3 (hu)
WO (1) WO2002064570A1 (hu)
ZA (1) ZA200305609B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100378097C (zh) * 2003-05-09 2008-04-02 弗·哈夫曼-拉罗切有限公司 作为α-1肾上腺素能激动剂的甲基吲哚和甲基吡咯并吡啶
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3202660A (en) * 1961-10-09 1965-08-24 Boehringer Sohn Ingelheim Process for the preparation of 3-arylamino-1, 3-diazacycloalkenes
HU192986B (en) * 1984-05-23 1987-08-28 Egyt Gyogyszervegyeszeti Gyar Process for production of imidasodiline derivatives
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
FR2761061B1 (fr) * 1997-03-20 1999-04-23 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives

Also Published As

Publication number Publication date
CA2437809A1 (en) 2002-08-22
WO2002064570A1 (de) 2002-08-22
EP1362038A1 (de) 2003-11-19
SK10132003A3 (sk) 2004-02-03
AR035226A1 (es) 2004-05-05
MXPA03007127A (es) 2003-11-18
HUP0303004A3 (en) 2004-07-28
CN1491216A (zh) 2004-04-21
BG108036A (bg) 2004-12-30
NO20033368L (no) 2003-07-28
NO20033368D0 (no) 2003-07-28
EE200300379A (et) 2003-12-15
EA200300835A1 (ru) 2004-02-26
KR20030076653A (ko) 2003-09-26
DE10106214A1 (de) 2002-08-14
JP2004517963A (ja) 2004-06-17
HUP0303004A2 (hu) 2003-12-29
ECSP034700A (es) 2003-08-29
CZ20032146A3 (cs) 2003-12-17
IL157297A0 (en) 2004-02-19
PL362149A1 (en) 2004-10-18
ZA200305609B (en) 2004-04-29

Similar Documents

Publication Publication Date Title
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
DE69925133D1 (de) Pyrrolobenzodiazepine
AP1853A (en) Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents.
ATE248837T1 (de) Chinuclidin-acrylamide
BR9909795A (pt) Derivados de epotilona 12, 13-modificados
BG106586A (en) Pyrazolopyramidines as therapeutic agents
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
BRPI0108395B8 (pt) derivados de pirrolopirimidinona, processos de preparação e uso
UY27629A1 (es) Nuevos anticolinérgicos, procedimiento para su preparación , así como su uso como medicamentos
SE0102036D0 (sv) Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
BR0215151A (pt) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6
IT1312115B1 (it) Composti amorfi e relative composizioni farmaceutiche
BR0307894A (pt) Heterocìclos tricìclicos fundidos úteis para o tratamento de distúrbios hiperproliferativos
SE0003476D0 (sv) Compounds
BR0001201A (pt) Composto ( poli ) tia-alcinóicos, composição cosmética, utilização de uma composição cosmética, utilização de um composto e composição farmacêutica
DE60128100D1 (de) Analgetisches arzneimittel
ATE259813T1 (de) Triazolopyrimidinderivate
BR0210746A (pt) Derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina tendo atividade antiviral
BR0206949A (pt) Derivados de alquil-fenilimino-imidazolidina para tratamento de incontinência urinária
ATE250610T1 (de) Kaliumkanal-blockierende mittel
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
BR0214529A (pt) compostos terapêuticos
AR022718A1 (es) 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-olessustituidos con n-(5-fenil-tetrahidrofuranil)metilo y n-(6-fenil-tetrahidropiranil)metilo;procedimientos para prepararlos y su empleo como composiciones farmaceuticas.
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]